Uncovering Genomic Evidence of SARS-CoV-2 Infection and Reinfection



Is it possible to become reinfected with SARS-CoV-2? If so, how can we identify and confirm reinfection?  What tools can we use to better identify prevalent and emerging strains of SARS-CoV-2?

Joel Sevinsky, Principal at Theiagen Consulting, is an expert in bioinformatics in the public health space and coauthor of a recent paper exploring the genomic evidence for reinfection with SARS-CoV-2 that was published in The Lancet Infectious Diseases. In this webinar, Dr. Sevinsky will discuss:
  • How next-generation sequencing (NGS) and off-the-shelf software confirmed the first documented SARS-CoV-2 reinfection case in the United States;
  • How bioinformatics analysis strongly supports the hypothesis that the patient was infected on two separate occasions by genetically distinct viruses;
  • The rationale for the continued use of NGS-based approaches for analysis and surveillance of SARS-CoV-2 samples.
Leif Schauser, Global Product Manager at Qiagen Digital Insights, will discuss recent product developments at Qiagen that support the detection, NGS analysis, and interpretation SARS-CoV-2-positive samples, including stain typing.  He will discuss solutions that range from Qiagen cloud-based services to scalable applications for on-premises analyses.

Добавить в избранное

Вам будет интересно